Wuxi Griffin Opens a New Aseptic Fill Finish Facility
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
On Jan. 4, 2018, contract manufacturer Wuxi Griffin announced the completion of a new 27,450-ft2 aseptic fill/finish facility in Wuxi, China. The facility is equipped with three filling suits and uses restricted access barrier systems and isolator production technology.
According to the company, the facility is compliant with GMP standards and offers manufacturing services for monoclonal antibodies, vaccines, recombinant proteins, biosimilars, and small-molecule drugs. Small- and medium-sized batch clinical trial manufacturing and commercial manufacturing are also available.
“There are few domestic Chinese contract manufacturers that are international players. There is a gap between the Chinese manufacturers capabilities and the regulatory requirements from the West. Wuxi Griffin is filling this gap by offering western GMP compliance from China,” said Torgny Lundgren, CEO of Wuxi Griffin, in a company press release.
Source: Wuxi Griffin
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
